Large burn wounds are a leading cause of morbidity and a major burden on Canadian patients and the health care system. Burns can be clinically treated by transplanting donor mesenchymal stromal cells (MSCs) that suppress inflammation and regenerate the recipient tissue. However, the stiff culture surfaces of bioreactors stress-activate MSCs during expansion into scar-promoting ‘myofibroblasts’ […]
Read More